Press "Enter" to skip to content

New patent expiration for Astrazeneca drug FASLODEX

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca drug FASLODEX

Annual Drug Patent Expirations for FASLODEX
Annual Drug Patent Expirations for FASLODEX

Faslodex is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for FASLODEX.

The generic ingredient in FASLODEX is fulvestrant. One supplier is listed for this compound. Additional details are available on the fulvestrant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca drug FASLODEX
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions